Preclinical study of simultaneous pharmacokinetic and pharmacodynamic herb-drug interactions between Yin-Chen-Hao-Tang and spironolactone

Abstract Background The prevalence and therapeutic effects of the use of herbal remedies for chronic liver diseases make the combined administration of herbal products with conventional treatment unable to be ignored. This study investigated the pharmacokinetic and pharmacodynamic herb-drug interact...

Full description

Bibliographic Details
Main Authors: Tun-Pin Hsueh, Tung-Hu Tsai
Format: Article
Language:English
Published: BMC 2020-08-01
Series:BMC Complementary Medicine and Therapies
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12906-020-03042-y
_version_ 1818479475154747392
author Tun-Pin Hsueh
Tung-Hu Tsai
author_facet Tun-Pin Hsueh
Tung-Hu Tsai
author_sort Tun-Pin Hsueh
collection DOAJ
description Abstract Background The prevalence and therapeutic effects of the use of herbal remedies for chronic liver diseases make the combined administration of herbal products with conventional treatment unable to be ignored. This study investigated the pharmacokinetic and pharmacodynamic herb-drug interactions between the herbal formula Yin-Chen-Hao-Tang (YCHT) and spironolactone. Methods A selective high-performance liquid chromatography (HPLC) method was developed and validated for the detection of spironolactone and its metabolite canrenone in rat urine. The interaction study was conducted by collecting urine samples after oral administration of spironolactone alone or in combination with YCHT for 5 days. Urine pharmacokinetic parameters and urinary sodium, potassium, volume, and weight were analyzed. Results The results revealed significant increases in the cumulative amount and the area under the rate curve (AURC) of the metabolite canrenone after pretreatment with the high dose of YCHT. The urine weight and volume were significantly reduced dose-dependently as a result of pretreatment with YCHT. The urinary sodium-to-potassium ratio, which indicates diuretic effects, was also reduced in the high-dose YCHT condition. Conclusions Herb-drug pharmacokinetic and pharmacodynamic interactions between YCHT and spironolactone were observed in the study. The herb-drug interaction that appeared with a single dose of spironolactone should be considered when patients are being treated with a continuous administration of this drug.
first_indexed 2024-12-10T11:11:04Z
format Article
id doaj.art-fe5c4973a36b46a4a369d50fb018e56e
institution Directory Open Access Journal
issn 2662-7671
language English
last_indexed 2024-12-10T11:11:04Z
publishDate 2020-08-01
publisher BMC
record_format Article
series BMC Complementary Medicine and Therapies
spelling doaj.art-fe5c4973a36b46a4a369d50fb018e56e2022-12-22T01:51:25ZengBMCBMC Complementary Medicine and Therapies2662-76712020-08-012011910.1186/s12906-020-03042-yPreclinical study of simultaneous pharmacokinetic and pharmacodynamic herb-drug interactions between Yin-Chen-Hao-Tang and spironolactoneTun-Pin Hsueh0Tung-Hu Tsai1Institute of Traditional Medicine, School of Medicine, National Yang-Ming UniversityInstitute of Traditional Medicine, School of Medicine, National Yang-Ming UniversityAbstract Background The prevalence and therapeutic effects of the use of herbal remedies for chronic liver diseases make the combined administration of herbal products with conventional treatment unable to be ignored. This study investigated the pharmacokinetic and pharmacodynamic herb-drug interactions between the herbal formula Yin-Chen-Hao-Tang (YCHT) and spironolactone. Methods A selective high-performance liquid chromatography (HPLC) method was developed and validated for the detection of spironolactone and its metabolite canrenone in rat urine. The interaction study was conducted by collecting urine samples after oral administration of spironolactone alone or in combination with YCHT for 5 days. Urine pharmacokinetic parameters and urinary sodium, potassium, volume, and weight were analyzed. Results The results revealed significant increases in the cumulative amount and the area under the rate curve (AURC) of the metabolite canrenone after pretreatment with the high dose of YCHT. The urine weight and volume were significantly reduced dose-dependently as a result of pretreatment with YCHT. The urinary sodium-to-potassium ratio, which indicates diuretic effects, was also reduced in the high-dose YCHT condition. Conclusions Herb-drug pharmacokinetic and pharmacodynamic interactions between YCHT and spironolactone were observed in the study. The herb-drug interaction that appeared with a single dose of spironolactone should be considered when patients are being treated with a continuous administration of this drug.http://link.springer.com/article/10.1186/s12906-020-03042-yArtemisiaDrug interactionHerbal medicineSpironolactoneLiver disease
spellingShingle Tun-Pin Hsueh
Tung-Hu Tsai
Preclinical study of simultaneous pharmacokinetic and pharmacodynamic herb-drug interactions between Yin-Chen-Hao-Tang and spironolactone
BMC Complementary Medicine and Therapies
Artemisia
Drug interaction
Herbal medicine
Spironolactone
Liver disease
title Preclinical study of simultaneous pharmacokinetic and pharmacodynamic herb-drug interactions between Yin-Chen-Hao-Tang and spironolactone
title_full Preclinical study of simultaneous pharmacokinetic and pharmacodynamic herb-drug interactions between Yin-Chen-Hao-Tang and spironolactone
title_fullStr Preclinical study of simultaneous pharmacokinetic and pharmacodynamic herb-drug interactions between Yin-Chen-Hao-Tang and spironolactone
title_full_unstemmed Preclinical study of simultaneous pharmacokinetic and pharmacodynamic herb-drug interactions between Yin-Chen-Hao-Tang and spironolactone
title_short Preclinical study of simultaneous pharmacokinetic and pharmacodynamic herb-drug interactions between Yin-Chen-Hao-Tang and spironolactone
title_sort preclinical study of simultaneous pharmacokinetic and pharmacodynamic herb drug interactions between yin chen hao tang and spironolactone
topic Artemisia
Drug interaction
Herbal medicine
Spironolactone
Liver disease
url http://link.springer.com/article/10.1186/s12906-020-03042-y
work_keys_str_mv AT tunpinhsueh preclinicalstudyofsimultaneouspharmacokineticandpharmacodynamicherbdruginteractionsbetweenyinchenhaotangandspironolactone
AT tunghutsai preclinicalstudyofsimultaneouspharmacokineticandpharmacodynamicherbdruginteractionsbetweenyinchenhaotangandspironolactone